One of the best brand of
whitening tablets in Japan. Transino is the best to remove skin blemishes and
melasma. Dark blurry spots around cheekbones...It might be Chloasma.
-Chloasma is dark blurry spots
which symmetrically spread around on top of cheekbones and under eyelids.
-Female hormonal imbalance,
Stress and exposure to the sun's UV rays
-Chloasma o often appears around
the age of 30 to 40 years old. Chloasma reduces aro und the age of 60 years and
older
-Mainly treated with oral
medicine. Tranexamic acid is effective.
Presentation
240 tablets
Feature
white tablets
Active Ingredients
Tranexamic acid - 750mg
L-Cysteine - 240mg
Vitamin C - 300mg
Added Vitamin B6 and Calcium
pantothenic acid
Primary Material
talc, synthetic phlogopite, nylon
-6, diisostearyl malate, squalane, silica, dimethicone, aluminium hydroxide,
phenyltrimethicone,
lauroyllysine, methicone, barium sulfate, tocopherol, aluminium dimyristate,
zinc oxide,
(dimethicone / methicone)
copolymers, phenoxyethanol, (+/- ) mica, Titanium oxide, iron oxide
Effect/Efficacy
Spots (limited to melasma)
Usage/Dosage
4 tablets a day (2 tablets/meal)
Cautions
(If you fail to follow these
precautions, your present symptoms may
worsen, or side effects may occur more readily.)
1. This product should not be
used by the following persons:
Persons who are getting dialysis
therapy (Convulsion may occur.)
2. Do not use the following
medicines while taking this product.
Oral medicines containing
tranexamic acid
Things
to consult
1. The following persons should
consult a doctor or pharmacist before use:
(1) Persons who are receiving
medical treatment from a doctor or den TIst.
(2) Women who are pregnant or
considered to be pregnant.
(3) Women who are breastfeeding.
(4) Persons aged 55 years or
over.
(5) Persons who have had allergic
symptoms with medicines or such.
(6) Persons who have thrombosis
(such as cerebral thrombosis, myocardial infarction, thrombophlebitis and pulmonary
embolism).
(7) Persons who may develop
thrombosis (persons who have had thrombosis, persons whose family
developed thrombosis, persons
whose doctor suggested they have congenital coagulation disorder, and
persons who are taking medicines
such as an oral contraceptive or hormone replacement therapy which
may cause thrombosis).
(8) Persons who have been
diagnosed as the following condition:
Kidney disease
● Do not use for more than 2 months in succession. However,
consecutive use for about one month is
needed before you notice the
effect of this product.
● If spots reappear after discontinuation of use, further
administration is available a after an interval of at
least 2 months. Also, after
re-starting use, do not continue to take this product for more than 2
months
Contraindication
Side effect rate was 5.2% in total
(6 incidents out of 115)
8 incidents: including 5
gastrointestinal disorder, 1 chest pain, 2 abnormal clinical test data.